COVID-19 and liver disease

JF Dufour, T Marjot, C Becchetti, H Tilg - Gut, 2022 - gut.bmj.com
Knowledge on SARS-CoV-2 infection and its resultant COVID-19 in liver diseases has
rapidly increased during the pandemic. Hereby, we review COVID-19 liver manifestations …

Vaccination in patients with kidney failure: lessons from COVID-19

N Babel, C Hugo, TH Westhoff - Nature Reviews Nephrology, 2022 - nature.com
Infection is the second leading cause of death in patients with chronic kidney disease (CKD).
Adequate humoral (antibody) and cellular (T cell-driven) immunity are required to minimize …

[HTML][HTML] Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic

T Reischig, M Kacer, T Vlas, P Drenko… - American Journal of …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination may fail
to sufficiently protect transplant recipients against coronavirus disease 2019 (COVID-19) …

[HTML][HTML] Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release …

M Crespo, A Barrilado-Jackson, E Padilla… - American Journal of …, 2022 - Elsevier
Studies are urgently needed to characterize immunogenicity, efficacy, and safety of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in kidney …

SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know

M Giannella, LC Pierrotti, I Helanterä… - Transplant …, 2021 - Wiley Online Library
In response to the COVID‐19 pandemic, SARS‐CoV‐2 vaccines have been developed at an
unparalleled speed, with 14 SARS‐CoV‐2 vaccines currently authorized. Solid‐organ …

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients

X Charmetant, M Espi, I Benotmane… - Science translational …, 2022 - science.org
Transplant recipients, who receive therapeutic immunosuppression to prevent graft
rejection, are characterized by high coronavirus disease 2019 (COVID-19)–related mortality …

Novel aspects of the immune response involved in the peritoneal damage in chronic kidney disease patients under dialysis

F Trionfetti, V Marchant, GT González-Mateo… - International Journal of …, 2023 - mdpi.com
Chronic kidney disease (CKD) incidence is growing worldwide, with a significant percentage
of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney …

COVID-19 and solid organ transplantation: Finding the right balance

R Opsomer, D Kuypers - Transplantation Reviews, 2022 - Elsevier
Background The COVID-19 pandemic has a great impact on solid organ transplant (SOT)
recipients due to their comorbidities and their maintenance immunosuppression. So far …

Immune responses to SARS-CoV-2 in dialysis and kidney transplantation

C Cantarelli, A Angeletti, L Perin, LS Russo… - Clinical Kidney …, 2022 - academic.oup.com
Despite progressive improvements in the management of patients with coronavirus disease
2019 (COVID-19), individuals with end-stage kidney disease (ESKD) are still at high risk of …

SARS-CoV-2-specific T cell responses in immunocompromised individuals with cancer, HIV or solid organ transplants

DB Reeg, M Hofmann, C Neumann-Haefelin… - Pathogens, 2023 - mdpi.com
Adaptive immune responses play an important role in the clinical course of SARS-CoV-2
infection. While evaluations of the virus-specific defense often focus on the humoral …